Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial - Gitelman, Stephen E; Gottlieb, Peter A; Rigby, Mark R; Felner, Eric I; Willi, Steven M; Fisher, Lynda K; Moran, Antoinette; Gottschalk, Michael; Moore, Wayne V; Pinckney, Ashley; Keyes-Elstein, Lynette; Aggarwal, Sudeepta; et al. (The lancet. Diabetes & endocrinology, 2013)
Keywords: Adolescent; Adult; Antilymphocyte Serum - therapeutic use; Child; Diabetes Mellitus, Type 1 - blood; Diabetes Mellitus, Type 1 - diagnosis; Diabetes Mellitus, Type 1 - drug therapy; Double-Blind Method; Endocrinology & Metabolism; Female; Humans; Immunologic Factors - therapeutic use; Male; Other; Time Factors; Treatment Outcome; Young Adult